Michael S. Conte

Michael S. Conte's AcademicInfluence.com Rankings

Michael S. Conte

Philosophy

#8529

World Rank

#11934

Historical Rank

Logic

#5561

World Rank

#6968

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Michael S. Conte's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Michael S. Conte Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael S. Conte's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). (2014) (986)
Global vascular guidelines on the management of chronic limb-threatening ischemia. (2019) (727)
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. (2006) (587)
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. (2015) (552)
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial (1999) (394)
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. (2009) (377)
The ideal small arterial substitute: a search for the Holy Grail? (1998) (256)
The natural history of untreated severe or critical limb ischemia. (2015) (246)
Clinical practice. Acute limb ischemia. (2012) (243)
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). (2015) (243)
Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer (2020) (229)
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. (2008) (226)
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. (2007) (210)
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. (2010) (191)
Inhibition of Vascular Smooth Muscle Cell Migration by Cytochrome P450 Epoxygenase-Derived Eicosanoids (2002) (181)
Disparity in Outcomes of Surgical Revascularization for Limb Salvage: Race and Gender Are Synergistic Determinants of Vein Graft Failure and Limb Loss (2009) (174)
Critical Limb Ischemia: Current Trends and Future Directions (2016) (169)
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. (2004) (162)
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. (2005) (151)
Inhibitor of apoptosis protein survivin regulates vascular injury (2002) (151)
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial (2016) (145)
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. (2007) (144)
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. (2008) (143)
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. (2007) (132)
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. (2009) (121)
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk. (2003) (121)
D‐series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury (2013) (118)
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. (2007) (116)
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. (2010) (114)
A systematic review and meta‐analysis of revascularization outcomes of infrainguinal chronic limb‐threatening ischemia (2018) (114)
Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial (2018) (110)
Impact of Increasing Comorbidity on Infrainguinal Reconstruction: A 20-Year Perspective (2001) (108)
Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study (2013) (108)
Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. (2009) (101)
Infrainguinal vein bypass graft revision: factors affecting long-term outcome. (2004) (99)
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. (2006) (98)
Preferred strategies for secondary infrainguinal bypass: lessons learned from 300 consecutive reoperations. (1995) (96)
The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. (2003) (93)
Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair. (2009) (93)
Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. (2004) (90)
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease (2017) (90)
Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein. (2002) (90)
A systematic review of treatment of intermittent claudication in the lower extremities. (2015) (88)
Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. (2003) (87)
Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. (2013) (86)
Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice (2015) (83)
A systematic review for the screening for peripheral arterial disease in asymptomatic patients. (2015) (83)
Vein graft failure. (2015) (83)
Surgical intervention for peripheral arterial disease. (2015) (82)
Short-term physical inactivity impairs vascular function. (2014) (81)
The impact of gender on the results of arterial bypass with in situ greater saphenous vein. (1995) (80)
Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes? (2001) (79)
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. (2007) (78)
Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. (1991) (76)
Understanding objective performance goals for critical limb ischemia trials. (2010) (75)
Clinical results of carotid artery stenting compared with carotid endarterectomy. (2008) (75)
D‐series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization (2016) (75)
Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. (2016) (75)
The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells (2014) (74)
Critical appraisal of surgical revascularization for critical limb ischemia. (2013) (74)
Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. (1994) (73)
Correction: Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication (Journal of Vascular Surgery (2015) 61(3S) (2S-41S)) (2015) (73)
Autogenous composite vein bypass graft for infrainguinal arterial reconstruction. (2001) (72)
Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. (2009) (71)
Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury. (1995) (70)
Bypass surgery versus endovascular interventions in severe or critical limb ischemia. (2016) (67)
Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. (2015) (65)
Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. (2006) (63)
Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. (2005) (61)
Lower extremity vein graft failure: a translational approach (2008) (59)
First Evidence that Bone Marrow Cells Contribute to the Construction of Tissue Engineered Vascular Autografts In Vivo (2004) (59)
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. (2011) (58)
Diabetic revascularization: endovascular versus open bypass--do we have the answer? (2012) (55)
Design and Rationale of the PREVENT III Clinical Trial: Edifoligide for the Prevention of Infrainguinal Vein Graft Failure (2005) (55)
Growing Impact of Restenosis on the Surgical Treatment of Peripheral Arterial Disease (2013) (54)
Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. (2008) (53)
Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial) (2015) (53)
Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury? (2001) (52)
Interventions for lower extremity peripheral artery disease (2018) (52)
Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. (2015) (52)
Effects of Gravitational Mechanical Unloading in Endothelial Cells: Association between Caveolins, Inflammation and Adhesion Molecules (2013) (51)
Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. (2006) (50)
Usefulness of autogenous bypass grafts originating distal to the groin. (2002) (50)
Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients (2012) (50)
Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. (2010) (49)
Pro-resolving lipid mediators in vascular disease. (2018) (49)
Regulation of Vein Graft Hyperplasia by Survivin, an Inhibitor of Apoptosis Protein (2005) (49)
Gender‐Specific Risk Factors for Peripheral Artery Disease in a Voluntary Screening Population (2014) (49)
Effect of renal insufficiency on outcome following infrarenal aortic surgery. (1997) (49)
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization. (2019) (46)
Genetic interventions for vein bypass graft disease: a review. (2002) (45)
Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. (2009) (43)
Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. (2011) (43)
Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs An Evaluation of the ClinicalTrials.gov Database (2012) (42)
Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling. (2004) (42)
Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. (2012) (42)
Femorotibial bypass for claudication: do results justify an aggressive approach? (1995) (42)
Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. (2017) (41)
Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. (2008) (41)
Molecular engineering of vein bypass grafts. (2007) (40)
Effect of a Home‐Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial (2018) (40)
Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries. (1995) (40)
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. (2006) (40)
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury (2017) (40)
Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? (2009) (40)
Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study. (2015) (39)
Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors. (2000) (39)
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. (2022) (37)
Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model (2018) (37)
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. (2009) (36)
Biosynthesis of proresolving lipid mediators by vascular cells and tissues (2017) (36)
Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit. (2002) (35)
Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. (2013) (35)
Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization. (2014) (35)
Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery. (2004) (32)
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. (2005) (31)
Nonrevascularization-based treatments in patients with severe or critical limb ischemia. (2015) (31)
An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. (2012) (31)
Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. (2012) (30)
Endothelial Function Predicts Positive Arterial-Venous Fistula Remodeling in Subjects with Stage IV and V Chronic Kidney Disease (2010) (30)
Advancing beyond the "heart-healthy diet" for peripheral arterial disease. (2015) (29)
Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts. (2007) (29)
Critical Limb Ischemia (2010) (29)
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. (2013) (29)
Molecular Identification of the Cross-reacting Epitope on αMβ2 Integrin I Domain Recognized by Anti-αIIbβ3 Monoclonal Antibody 7E3 and Its Involvement in Leukocyte Adherence* (1998) (29)
Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. (2010) (29)
Setting high-impact clinical research priorities for the Society for Vascular Surgery. (2013) (29)
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model (2018) (29)
Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance. (2014) (28)
Atherosclerotic Peripheral Vascular Disease Symposium II: Lower-Extremity Revascularization: State of the Art (2008) (28)
Determinants of midterm functional outcomes, wound healing, and resources used in a hospital‐based limb preservation program (2017) (27)
Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial). (2019) (27)
Polyunsaturated fatty acids and peripheral artery disease (2012) (27)
Predictors of major amputation despite patent bypass grafts. (2013) (27)
Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries. (2001) (25)
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial (2013) (25)
Relationship Between Global Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial. (2020) (25)
Advances in Revascularization for Peripheral Artery Disease (2021) (24)
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway (2017) (24)
Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. (2019) (22)
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. (2019) (22)
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. (2012) (22)
Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease. (1999) (22)
Retroviral gene transfer: effects on endothelial cell phenotype. (1998) (22)
Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program (2020) (21)
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. (2012) (20)
MEANINGFUL CHANGE IN SIX-MINUTE WALK IN PEOPLE WITH PERIPHERAL ARTERY DISEASE. (2020) (20)
Carotid endarterectomy: who is the high-risk patient? (2004) (20)
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. (2012) (20)
Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. (2017) (20)
A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. (2013) (19)
Adventitial Nab-Rapamycin Injection Reduces Porcine Femoral Artery Luminal Stenosis Induced by Balloon Angioplasty via Inhibition of Medial Proliferation and Adventitial Inflammation (2012) (19)
Cryopreserved saphenous vein as a last‐ditch conduit for limb salvage: From the Western Vascular Society (2016) (19)
Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass. (2007) (19)
Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo (2020) (19)
Survivin regulation of vascular injury. (2006) (19)
The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program. (2015) (19)
Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization. (2019) (19)
Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. (2009) (19)
C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta. (2008) (18)
In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: Application of high‐resolution inner‐volume black blood 3D FSE (2009) (18)
Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures? (2008) (18)
Re-publication: A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. (2019) (18)
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. Discussion and Commentary (2007) (17)
Restenosis After Carotid Endarterectomy Performed With Routine Intraoperative Duplex Ultrasonography and Arterial Patch Closure: A Contemporary Series (2007) (17)
Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease. (2019) (16)
Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. (2020) (16)
Lower-extremity arterial disease. (2005) (15)
The Global Limb Anatomic Staging System (GLASS) is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia. (2021) (15)
Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. (2017) (15)
Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease (2015) (15)
Angiogenesis: From the molecular to integrative pharmacology (2002) (15)
Transcription Factor Decoys for the Prevention of Vein Bypass Graft Failure (2003) (15)
Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no‐option chronic limb‐threatening ischemia (2018) (15)
High‐resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE (2008) (15)
Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease (2020) (14)
Patient complexity by surgical specialty does not correlate with work relative value units. (2020) (14)
Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. (2014) (14)
Society for Vascular Surgery Appropriate Use Criteria for Management of Intermittent Claudication. (2022) (14)
Endovascular Interventions for Claudication Do Not Meet Minimum Standards for the Society for Vascular Surgery Efficacy Guidelines. (2020) (13)
Medical management of peripheral arterial disease: bridging the "gap"? (2012) (13)
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. (2011) (13)
Transaortc Endarterectomy for Primary Mesenteric Revascularization (2002) (12)
RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. (2011) (12)
Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. (2013) (12)
Relationship between kidney disease and endothelial function in peripheral artery disease. (2014) (11)
Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes (2017) (11)
Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo. (2012) (11)
Primary stenting in femoropopliteal occlusive disease - what is the appropriate role? (2015) (11)
Monocyte adhesion to balloon-injured arteries: the influence of endothelial cell seeding. (2001) (11)
Repopulation of injured arteries with genetically modified endothelial cells. (1992) (10)
Gene Therapy for the Extension of Vein Graft Patency: A Review (2005) (9)
Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts (2010) (9)
Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease (2015) (8)
The PREVENT Trial of vein graft genetic engineering Preliminary molecular and clinical findings (1998) (8)
Pedal arterial calcification score is associated with risk of major amputation in chronic limb-threatening ischemia. (2021) (8)
Buflomedil in peripheral arterial disease: trials and tribulations. (2008) (8)
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization. (2019) (8)
Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. (2019) (7)
Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: (2015) (7)
PP44. Determinants of Hospital Disposition after Lower Extremity Bypass Surgery (2009) (7)
Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109]. (2019) (7)
Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease. (2014) (7)
External validation of the Vascular Quality Initiative prediction model for survival in no-option chronic limb-threatening ischemia patients. (2020) (7)
Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging (2008) (7)
Antegrade common femoral artery closure device use is associated with decreased complications. (2019) (6)
RR21. Society for Vascular Surgery (SVS) Lower Extremity Threatened Limb Classification Discriminates Early Outcomes in Hospitalized Patients (2014) (6)
Arterial Reconstruction for Lower Limb Ischemia (2001) (6)
Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. (1998) (6)
Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the Society for Vascular Surgery Threatened Limb Classification System (WIfI). (2020) (6)
Data, guidelines, and practice of revascularization for claudication. (2017) (5)
Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)) (2015) (5)
Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia. (2013) (5)
The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement (2021) (5)
Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy. (2002) (4)
Depression Predicts Non-Home Discharge After Abdominal Aortic Aneurysm Repair. (2021) (4)
Endovascular Treatment of High-Risk Peripheral Vascular Occlusive Lesions: A Review of Current Evidence and Emerging Applications of Intravascular Lithotripsy, Atherectomy, and Paclitaxel Coated Devices (2021) (4)
Regulation of Vascular Smooth Muscle Cell Growth by Survivin (2007) (4)
SS19. SVS Limb Stage (WIfI) and Patient Risk (PIII) Correlate With Midterm Outcomes in an Amputation Prevention Program (2015) (4)
Patients with Depression Are Less Likely to Go Home After Critical Limb Revascularization. (2020) (4)
Current Therapy in Vascular Surgery, 4th Edition (2001) (4)
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial (2020) (4)
Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia. (2020) (4)
Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs. (1998) (3)
Infrainguinal arterial reconstructions with vein grafts in patients with prior aortic procedures: the influence of aneurysm and occlusive disease. (2000) (3)
Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review. (2021) (3)
Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia. (2022) (3)
Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies (2021) (3)
Increased Re-Intervention Following Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women. (2020) (3)
Living in a Food Desert is Associated with 30-day Readmission After Revascularization for Chronic Limb-Threatening Ischemia. (2020) (3)
Natural History of Acute Pediatric Iliofemoral Artery Thrombosis Treated with Antithrombotic Therapy. (2020) (3)
Closure Device Use for Common Femoral Artery Antegrade Access is Higher Risk than Retrograde Access. (2021) (3)
Applicability of the Vascular Quality Initiative (VQI) mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population. (2022) (3)
Risk score for nonhome discharge after lower extremity bypass. (2020) (3)
RR21. Early (30 Day) Vein Remodeling is Predictive of Mid-Term Graft PatencY Following Lower Extremity Bypass (2011) (3)
Consensus-based perioperative protocols during the COVID-19 pandemic. (2020) (3)
Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. (2010) (2)
Practice Patterns Surrounding the Use of Tibial Interventions for Claudication in the Medicare Population. (2022) (2)
Lower Extremity Revascularization in the Medicare Population: The Ongoing Rise of Office‐Based Atherectomy (2018) (2)
Delirium Associated Adverse Events And Resource Use After Infrainguinal Lower Extremity Bypass (2022) (2)
Infraclavicular First Rib Resection for Focused and Effective Treatment of Venous Thoracic Outlet Syndrome (2010) (2)
Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia (2021) (2)
Determinants of Midterm Functional Outcomes and Wound Healing in a Hospital-Based Limb Preservation Program. (2016) (2)
Corrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>]. (2020) (2)
Video-assisted parathyroidectomy (2001) (2)
Genetic Therapy for Vein Bypass Graft Disease: Current Perspectives (2004) (2)
High-Resolution T 1-And T 2-Weighted Black Blood Inner Volume 3 D Fast Spin Echo Imaging For Characterizing Vessel Wall Components In Vivo (2007) (2)
Endothelialization of prosthetic vascular grafts: current status and future directions. (1995) (2)
Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center. (2021) (2)
A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia (2022) (2)
Pedal Arterial Calcification Score Correlates With Risk of Major Amputation in Chronic Limb-Threatening Ischemia (2020) (2)
Appropriate use of revascularization for claudication. (2020) (1)
Cryopreserved Saphenous Vein: Last-Ditch Conduit for Limb Salvage? (2016) (1)
Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial". (2011) (1)
Abstract 492: Resolvin D2 Inhibits Murine Abdominal Aortic Aneurysm and Increases M2 Macrophage Differentiation (2014) (1)
Association of Intraoperative and Perioperative Transfusions with Postoperative Cardiovascular Events and Mortality after Infrainguinal Revascularization. (2022) (1)
The New Global Limb Anatomic Staging System (GLASS) for CLTI: Assessment of its Utility in Two Limb Preservation Centers (2019) (1)
Presentation of Symptomatic PAD in Patients with Chronic HIV Infection (2014) (1)
Peripheral Arterial Disease in the Elderly (2017) (1)
An Integrated Biochemical Prediction Model of All-Cause Mortality in Patients Undergoing Lower Extremity Bypass Surgery for Advanced Peripheral Artery Disease (2012) (1)
A Synthetic Resolvin Analogue (Benzo-Rvd1) Attenuates Vascular Smooth Muscle Cell Migration and Neointimal Hyperplasia (2020) (1)
The Effects of Polyunsaturated Fatty Acids on Monocyte-Endothelial Cell Interactions (2012) (1)
Gender Disparities in Presentation, Operative Characteristics, and Clinical Outcomes After Lower Extremity Bypass for Peripheral Artery Disease (2020) (1)
Pedal Arterial Calcification Score Is Associated With Hemodynamic Change and Major Amputation After Revascularization in Chronic Limb-Threatening Ischemia (2021) (1)
Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia. (2022) (1)
Gender Disparities in Presentation, Treatment, and Outcomes of Critical Limb Ischemia (2020) (1)
Invasive treatment of claudication: Time for better measures and better controls. (2021) (1)
Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): Protocol for randomized controlled trial (2012) (1)
Abstract 134: Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Downstream n-3 Fatty Acid Metabolites in Patients With Peripheral Artery Disease (2014) (1)
17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury (2022) (1)
gene is associated with primary patency of lower extremity vein bypass grafts (2013) (1)
Mechanisms of statin-mediated smooth muscle cell apoptosis: a role for survivin (SVV) (2005) (1)
Racial and Ethnic Disparities in Major Adverse Limb Events Persist for Chronic Limb Threatening Ischemia Despite Presenting Limb Threat Severity After Peripheral Vascular Intervention. (2022) (1)
A critical appraisal of registry-based objective performance goals in peripheral arterial disease. (2021) (1)
IF02. Angiographic Patterns at the Ankle and Foot Level in Patients With Critical Limb-Threatening Ischemia Correlate With Healing of Transmetatarsal Amputation (2019) (1)
Discussion: Open Surgical Revascularization for Wound Healing: Past Performance and Future Directions; and Discussion: Critical Evaluation of Endovascular Surgery for Limb Salvage (2011) (1)
Structured Discharge Documentation Reduces Sex-based Disparities in Statin Prescription in Vascular Surgery Patients. (2023) (1)
PS212. Peri-Adventitial Delivery of a Nanoparticle Albumin-Bound Rapamycin Reduces Luminal Stenosis in a Porcine Femoral Artery Balloon Injury Model (2011) (1)
Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients (2011) (1)
Understanding Value and Patient Complexity Among Common Inpatient Vascular Surgery Procedures (2020) (1)
A systematic review andmeta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia (2018) (1)
PS142. Do Objective Performance Goals (OPGs) for Critical Limb Ischemia (CLI) Apply to Everyday Vascular Surgery Practice (2010) (1)
C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor- (cid:1) (2008) (1)
Erratum to: Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients (2011) (1)
PS150. Determinants of Endothelial Dysfunction in Peripheral Artery Disease: Importance of Kidney Disease (2014) (1)
Assessing drug elution technologies in the superficial femoral artery. (2011) (1)
The Significance of the Global Vascular Guidelines for Podiatrists: Answers to Key Questions in the Diagnosis and Management of the Threatened Limb. (2021) (1)
Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease". (2014) (1)
Decreasing Prevalence of Centers Meeting the Society for Vascular Surgery Abdominal Aortic Aneurysm Guidelines in the United States (2021) (1)
Abstract 24: Resolvin D2 Reduces Thrombus Burden and Attenuates Inflammatory Signaling Pathways in a Murine Model of Venous Thrombosis (2015) (1)
Open revascularization approach is associated with healing and ambulation following transmetatarsal amputation in patients with chronic limb threatening ischemia. (2022) (0)
Monocyte Adhesion to Injured Vessels: Specific Inhibition of Fibrinogen/Mac-1 Interaction by 1-Domain Peptide (1999) (0)
Abstract 210: Biosynthesis of D-series Resolvin by Isolated Vascular Cells and Tissues (2015) (0)
Thirty-Day Readmission Following Lower Extremity Bypass for Critical Limb Ischemia (CLI) in the PREVENT III Cohort (2012) (0)
Sex-based Disparities In Major Adverse Limb Events Highest For Femoropopliteal Intervention After Accounting For Presenting Wifi Stage For Chronic Limb Threatening Ischemia (2023) (0)
Abstract 318: Determinants of Red Blood Cell Omega-3-Fatty Acid Content in Patients With Peripheral Arterial Disease (2014) (0)
Midterm Outcomes of Neuroischemic and Ischemic Wounds Treated by a Multidisciplinary Limb Salvage Service (2013) (0)
Upregulation of Mitochondrial Chaperone Proteins in Vein Grafts: A Potential Mechanism of Apoptosis-Resistance in the Arterialized Vein (2011) (0)
SS5. Soluble Inflammatory and Cellular Adhesion Molecules Predict Mortality, Cardiovascular events (MACE), and Amputation-Free Survival (AFS) in Patients Undergoing Lower Extremity Vein Bypass Surgery (2009) (0)
Abstract 363: Prolonged Upregulation of Proinflammatory and Profibrotic Genes is Characteristic of Successful Arteriovenous Fistula Maturation (2014) (0)
Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia. (2022) (0)
Antegrade Common Femoral Artery Closure Device Use Is Safe and Associated With Decreased Complications (2019) (0)
In-Network Primary Care: An Important Augmentation To Preoperative Workup For Patients Undergoing Infrainguinal Bypass (2021) (0)
Suggested object ive performance goals and clinical trial design for evaluating catheter-based treatment of crit ical limb ischemia (2018) (0)
Abstract 187: Regulation of Vascular Smooth Muscle Cell (VSMC) Inflammation and Migration by the Pro-resolving Lipid Mediator Maresin-1 (mar1) (2013) (0)
Arteries With Autologous Genetically Modified Endothelial Cells (2005) (0)
Capturing the Complexity of Open Abdominal Aortic Surgery in the Endovascular Era. (2022) (0)
Portasystemic Venous Shunt Surgery for Portal Hypertension (2003) (0)
Monitoring Tissue Oxygen Dynamics with a Novel Implantable Hydrogel Sensor in Patients with Peripheral Arterial Disease Comparative Assessment of Peripheral Stent Abrasiveness under Cyclic Deformations Experienced During Limb Flexion (2022) (0)
Analysis of a Machine Learning–Based Risk Stratification Scheme for Chronic Limb-Threatening Ischemia (2022) (0)
Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia (2023) (0)
SS25. Cryopreserved Venous Allograft: An Alternative Conduit for Reconstruction of Infected Prosthetic Aortic Grafts (2009) (0)
Vascular Disease Critical Limb Ischemia (2017) (0)
Perivascular Delivery of Resolvin D 1 Inhibits Inflammation and Neointimal Hyperplasia in a Rabbit Vein Graft Model (2017) (0)
High-Risk Clinical Predictors and Associated Morbidity of Acute Kidney Injury Following Thoracic Endovascular Aortic Repair for Aortic Aneurysm (2022) (0)
Effects of Mechanical Gravitational Unloading on Vascular Endothelial Cells Function (2013) (0)
Gender-Based Differences in the Inflammatory Profile of Peripheral Arterial Disease and Their Association with Outcomes of Lower Extremity Vein Bypass Surgery (2011) (0)
Reply (2022) (0)
Vascular health and the health of vascular surgery-2021 Western Vascular Society Presidential Address. (2023) (0)
Abstract 251: Effects of n-3 Fatty Acids Supplementation on Endothelial Function and Inflammation in Peripheral Artery Disease: The OMEGA-PAD Trial (2013) (0)
Relationship between WIfI (wound, ischemia, foot infection) stage and quality of life at revascularization in the BEST-CLI (best endovascular versus best surgical therapy in patients with chronic limb threatening ischemia) trial (2023) (0)
Abstract 300: A Biodegradable Wrap for Peri-vascular Delivery of Pro-resolving Lipid Mediators (2015) (0)
IS-8-KL Revascularization for critical limb ischemia : Strategies and evidence(IS-8 Surgical treatment for severe limb ischemia from the point of long term outcome) (2011) (0)
Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index (2010) (0)
Venous Thromboembolism After Vascular Surgery: Is More Aggressive Chemoprophylaxis Warranted? (2021) (0)
Novel Preoperative Risk Score to Identify Patients at High Risk for Non-Home Discharge after Elective Thoracic Endovascular Aortic Aneurysm Repair (2019) (0)
Publishing Your Clinical Trial (2020) (0)
Abstract 314: Determinants of Endothelial Dysfunction in Peripheral Artery Disease: Importance of Kidney Disease (2014) (0)
Oral Supplementation With High-Dose Fish Oil Alters Circulating Leukocyte Resolution Phenotype in Healthy Subjects and Patients With Peripheral Arterial Disease (2017) (0)
Understanding Value and Patient Complexity Among Common Inpatient Vascular Surgery Procedures. (2021) (0)
Invited commentary. (2018) (0)
Where do We Go to in the Treatment of Acute Limb Ischaemia? (2020) (0)
Abstract 20: Resolution Phenotype of Monocytes and Macrophages is Altered in Peripheral Arterial Disease (2017) (0)
Abstract 279: Resolvin D2 and Maresin 1 Modulate Vascular Inflammation, Cell Migration Aad Macrophage Polarization in a Mouse Model of Arterial Injury (2015) (0)
Iliac Artery Calcification Burden is Associated With Adverse Cardiovascular Outcomes and Mortality After Infrainguinal Revascularization for Chronic Limb-threatening Ischemia (2021) (0)
Effect of Preoperative Aspirin, Beta-Blocker, and Statin Usage on Perioperative and One-Year Mortality of Abdominal Aortic Aneurysm Repair (2021) (0)
n-3 polyunsaturated fatty acids to heal the broken heart (2013) (0)
Risk Factors for 30 Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease (2013) (0)
INVITED COMMENTARY (2017) (0)
Suture Aneurysmorrhaphy for Salvage of Bleeding Arteriovenous Fistula Aneurysms (2015) (0)
Chapter 10 Molecular engineering of vein bypass grafts (2007) (0)
Capturing the Complexity of Open Abdominal Aortic Surgery in the Endovascular Era (2021) (0)
Turndown for Ruptured Abdominal Aortic Aneurysm Repair Based On Sex in the United States (2021) (0)
A Novel Preoperative Risk Score for Non-Home Discharge After Elective Thoracic Endovascular Aortic Repair. (2020) (0)
Reply. (2020) (0)
Eliminating Sex-Based Disparities in Statin Prescriptions Following Open Revascularization for CLTI Through Universal Documentation (2022) (0)
PS196. Mitochondrial Heat Shock Proteins Regulate Vascular Smooth Muscle Cell Responses to Oxidant Stress and Determine Apoptotic Threshold (2011) (0)
Clinical Effectiveness and Resource Utilization of Surgery vs Endovascular Therapy for Chronic Limb Threatening Ischemia. (2020) (0)
Reply. (2020) (0)
Social Vulnerability Is Associated with Worse Two-Year Survival after Lower Extremity Bypass (2022) (0)
Female Gender is Associated With Lower Quality of Life in Patients With Chronic Limb Threatening Ischemia as Determined by Review of BEST-CLI Patients (2022) (0)
Poor Medical Management, Atherectomy, and Multilevel Therapy Are Associated With Worse Outcomes After Endovascular Interventions for Claudication (2019) (0)
The Global Limb Anatomic Staging System Predicts Clinical Outcomes in Chronic Limb Threatening Ischemia (2020) (0)
Food Deserts Associated With Increased Wound Complications After Major Vascular Procedures (2021) (0)
An Apple A Day Keeps The Hospital Away: Food Deserts Are Associated With 30-day Readmission After Revascularization For Chronic Limb Threatening Ischemia (2020) (0)
Thoracic Endovascular Aortic Repair for Aortic Aneurysm Is Safe in Patients With Chronic Kidney Disease, but at a Cost (2020) (0)
Endothelial Function and Geometric Remodeling of Arterialized Vein Grafts Are Asynchronous (2013) (0)
Leukocyte Phenotype Is Altered in Peripheral Arterial Disease (2018) (0)
COMPARING SIX-MINUTE WALK VS. TREADMILL WALKING DISTANCE AS OUTCOMES IN RANDOMIZED TRIALS OF PERIPHERAL ARTERY DISEASE (2020) (0)
Closure Device Use For Common Femoral Artery Antegrade Access Is Higher Risk Than Retrograde Access (2021) (0)
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, r a n d o m i s e d , c o n t r o l l e dt r i a l (1999) (0)
PS204. Mechanical (or “Gravitational”) Unloading Reduces Inflammatory and Cell Adhesion Molecule Gene Expression in Human Endothelial Cells (2012) (0)
Abstract 289: Peripheral Arterial Disease and Vulnerability to Cardiovascular Events: Data from the Heart and Soul Study (2012) (0)
Presenting Severity of Limb Threat Does Not Account for Racial and Ethnic Disparities in Major Adverse Limb Events After Peripheral Vascular Intervention for Chronic Limb-Threatening Ischemia (2022) (0)
PS208. Cytostatic Gene Therapy: RNAi-Mediated Survivin Knockdown Induces Cell Cycle Arrest, Polyploidy, and Reduced Migration of Vascular Smooth Muscle Cells (VS MC) (2010) (0)
Abstract 314: Development of a Nanotube-coated Nitinol Stent for Delivery of Resolvin D1 (2016) (0)
Abstract 657: Resolvin D1 Attenuates Vascular Smooth Muscle Cell Migration via the cAMP Pathway (2015) (0)
Surgical revascularization. Introduction. (2009) (0)
The Vascular Quality Initiative Chronic Limb-Threatening Ischemia Mortality Prediction Model Underestimates Mortality After Infrainguinal Revascularization (2021) (0)
Lower Extremity Revascularization With Transmetatarsal Amputation Improves Healing and Reduces Major Amputation (2018) (0)
PREVENT III and IV Trials of E 2 F Decoy : What Have We Learned ? (2006) (0)
A Limb is a Peninsula- and No Clinician is an Island: Introducing the American Limb Preservation Society (ALPS). (2021) (0)
The Growing Burden of Restenosis in Peripheral Arterial Disease and Its Impact on Outcomes (2013) (0)
Unrecognized Cognitive Impairment Is Common In A VA Population With Peripheral Arterial Disease (2022) (0)
P25: The effect of socioeconomics on procedural outcomes: The interactions and impact between race and income on mortality, disposition, and resource utilization (2007) (0)
Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Mid-Term Amputation Free Survival After Lower Extremity Bypass for Peripheral Arterial Disease. (2022) (0)
Abstract 262: Circulating Exosomes from PAD Patients Modulate Vascular Repair and Inflammation (2018) (0)
Surgery 6-13-2010 Critical limb ischemia (2018) (0)
IP039. Depression Predicts Nonhome Discharge After Abdominal Aortic Aneurysm Repair (2019) (0)
Initial Improvement in Ankle‐Brachial Index After Vein Bypass for Rest Pain Predicts Limb Salvage: IP203. (2018) (0)
Session IV: Preventing Intimal Hyperplasia and Other Adjuncts to Endovascular Treatment (2004) (0)
Vitamin D Deficiency Is Associated With Mortality and Adverse Vascular Access Outcomes in the ESRD Population (2013) (0)
Cognitive Impairment is Common in a Veterans Affairs Population with Peripheral Arterial Disease. (2022) (0)
Abstract 285: Rapid Change In Red Blood Cell PUFA Composition With High-dose Fish Oil Supplementation In Patients With Peripheral Artery Disease (PAD). (2015) (0)
Abstract 303: Monitoring Tissue Oxygen Dynamics With A Novel Implantable Hydrogel Sensor In Patients With Pad (2022) (0)
Evaluation and Treatment of Patients With Lower Extremity Peripheral ArteryDisease (2015) (0)
TCT-555 The Association of Health-Related Quality-of-Life Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID Trial (2019) (0)
WIfI Staging and Long-term Outcomes After Infrainguinal Revascularization for Chronic Limb-threatening Ischemia (2022) (0)
Viabahn Treatment for Femoropopliteal Occlusive Disease: Relationship between Implant Length and Clinical Outcomes (2011) (0)
Clinical Predictors and Outcomes Associated with Postoperative Delirium Following Infrainguinal Bypass Surgery. (2022) (0)
Abstract 222: D-Series Resolvins Modulate Postinjury Signaling Pathways in Vascular Smooth Muscle Cells (2012) (0)
TCT-439: Peri-adventitial Delivery of a Nanoparticle Albumin-Bound (nab) Rapamycin Solution Reduces Luminal Stenosis in a Porcine Femoral Artery Balloon Injury Model (2016) (0)
The Association Between Erythrocyte n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Content and Inflammation in Male Patients With Peripheral Artery Disease (PAD) (2013) (0)
Effectiveness of a Home-Based Exercise Program on Walking Ability in Patients with Peripheral Artery Disease—The HONOR Trial (2020) (0)
Patient Complexity Varies by Surgical Specialty and Does Not Strongly Correlate with Work Relative Value Units (2019) (0)
Abstract 109: Exosomes from Mesenchymal Stem Cells Suppress Aortic Elastin Induced Inflammation in Macrophages (2018) (0)
Evaluation of the Global Limb Anatomic Staging System in patients with chronic limb threatening ischaemia undergoing endovascular intervention for femoro-popliteal disease. (2022) (0)
Adiponectin, an Anti-Inflammatory Adipokine, Modulates Inflammatory Protein Expression and Human Saphenous Vein Endothelial Cell Phenotype: Implications for Bypass Graft Failure (2011) (0)
Upregulated expression of mineralocorticoid receptor (MR) in vein grafts: A potential role for aldosterone signaling in vein graft disease (2006) (0)
Living in a Food Desert is Associated With Increased Wound Complications After Major Vascular Procedures (2021) (0)
Abstract 13208: Pedal Arterial Calcification Score Correlates With Risk of Death and Major Adverse Cardiovascular Event in Patients With Chronic Limb Threatening Ischemia (2020) (0)
Beyond Arterial Stenosis: Walking Disability in PAD Patients Is Related to Arterial Endothelial Function (2013) (0)
JAMA Cardiology List of Peer Reviewers. (2017) (0)
The Offspring of Sisyphus: Steady Progress in The Decade Since the "Toe and Flow" JAPMA-JVS Special Issue on Limb Preservation. (2021) (0)
Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia (2023) (0)
Contemporary Experience With Paravisceral Aortic Aneurysm Repair in an Experienced Endovascular Center (2020) (0)
The role of survivin in regulation of cytokine/growth factor signaling in vascular smooth muscle cells (2006) (0)
Adjunctive Dexamethasone Infusion into the Adventitia of the Femoro-popliteal Artery to Enhance Clinical Efficacy Following Endovascular Revascularization: A Proof of Concept First in Man Study (2013) (0)
Room for Improvement: Age-Friendly 4M Assessments in a Veterans Affairs Vascular Surgery Clinic (2022) (0)
Abstract 15937: Gender Disparities in Presentation and Outcomes for Patients Undergoing Endovascular Lower Extremity Interventions for Peripheral Artery Disease (2020) (0)
Session XVIII: New Developments in the Prevention of Intimal Hyperplasia in the Treatment of Lower Extremity Ischemia (2004) (0)
Natural History of Acute Pediatric Iliofemoral Artery Thrombosis Treated With Antithrombotic Therapy (2019) (0)
Erratum to: Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients (2011) (0)
Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes (2020) (0)
Predictors of Amputation-Free Survival and Wound Healing After Infrainguinal Bypass with Alternative Conduits (2021) (0)
Iliac Artery Calcification Score Stratifies Mortality Risk Estimation in Patients with Chronic Limb-Threatening Ischemia Undergoing Revascularization. (2023) (0)
Pedal Arterial Calcification Is Associated With Progression From Transmetatarsal Amputation To Major Amputation Following Infrainguinal Revascularization For Chronic Limb-threatening Ischemia (2023) (0)
Short-Term , High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid – Derived Mediators in Patients With Peripheral Artery Disease (2015) (0)
Pedal Arterial Calcification Score Is Associated With Lack of Hemodynamic Improvement and Major Amputation After Revascularization in Chronic Limb-Threatening Ischemia (2021) (0)
Novel Strong Association Between Bone Mineral Density Scores and the Prevalence of Peripheral Arterial Disease in Both Sexes (2015) (0)
SS3. Validation of the PIII CLI Risk Score for the Prediction of Amputation-Free Survival (AFS) in Patients with Critical Limb Ischemia (2009) (0)
Patients with Depression Are Less Likely to Go Home after Critical Limb Revascularization (2019) (0)
Peripheral Vascular Disease - Fellows in Training Workshop (2014) (0)
Limb-Based Patency Defines Effective Revascularization for Chronic Limb-Threatening Ischemia (2021) (0)
Abstract 353: Mechanical (or “Gravitational”) Unloading Reduces Inflammatory and Cell Adhesion Molecule Gene Expression in Human Endothelial Cells (2012) (0)
Abstract 248: Role of Mitochondrial Heat-Shock Protein 90 (HSP90) in Regulation of Vascular Smooth Muscle Cell (VSMC) Apoptosis and Vascular Remodeling in-vivo (2013) (0)
Surgical Treatment of Infrainguinal Occlusive Disease in Diabetes (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael S. Conte?

Michael S. Conte is affiliated with the following schools:

Boston University
University of Massachusetts Medical School
University of California, San Francisco